Development of Early Diagnosis and Therapeutic Agent for CTEPH Focused on a Novel Pathogenic Protein TAFI
Open Access
- 10 August 2019
- journal article
- Published by Japan College of Angiology in The Journal of Japanese College of Angiology
- Vol. 59 (8), 61-67
- https://doi.org/10.7133/jca.19-00011
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Recent Advances in the Understanding of ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2019
- Tissue FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2018
- Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complicationsEuropean Heart Journal, 2017
- Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary HypertensionCirculation Research, 2017
- Novel Therapeutic Targets of Pulmonary HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Basigin Mediates Pulmonary Hypertension by Promoting Inflammation and Vascular Smooth Muscle Cell ProliferationCirculation Research, 2014
- OCT Imaging for the Management of Pulmonary HypertensionJACC: Cardiovascular Imaging, 2014
- Update on Chronic Thromboembolic Pulmonary HypertensionJournal of the American College of Cardiology, 2014
- Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in MiceJournal of the American College of Cardiology, 2006